IBRX

NASDAQ · Biotechnology

Immunitybio Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.29

+0.84 (+9.94%)

As of Sep 22, 9:50 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +1,071.0% upside

Low Target $71.54

Average Target $108.79

High Target $142.95

Current Price $9.29

Current
$9.29

Target
$108.79

$71.54 $108.79 avg $142.95

Scenario Analysis

Bear Case

$71.54

670.1%

Low target

Base Case

$108.79

+1,071.0%

Avg target

Bull Case

$142.95

+1,438.8%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$12.43

-25.3% from high

52-Week Low

$1.95

+376.4% from low

50-Day SMA

$4.22

+120.1% vs SMA

200-Day SMA

$2.95

+214.9% vs SMA

RSI (14)

70.9

Overbought

Target vs 52W High

$108.79

+775.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%